生命科学资讯

Moderna accuses FDA of shifting standard as agency refuses flu shot review

Isomorphic claims major advance with new AI drug design engine

ILiAD raises $115M round to advance whooping cough vaccine

AbbVie, AstraZeneca lose appeal in Louisiana 340B contract pharmacy fight

NIH stops low-dose Xarelto arm of large stroke study due to safety concerns

Is AstraZeneca on track to meet its $80B revenue target?

The fallout from Novo vs. Hims

Shanghai's Cascade gets $72M to pursue MASH, obesity and diabetes drugs

Nektar posts one-year eczema success; Pfizer ends malnutrition trial

CSL’s Paul McKenzie out, as Gordon Naylor named interim CEO

AstraZeneca’s obesity pill hits in Phase 2, key cancer trials pushed back

'Bat-sh*t crazy': Biopharma leaders unload on regulatory chaos

Hengrui, Kailera push obesity pill ahead on promising mid-stage China data

FDA rejects Regenxbio's Hunter syndrome gene therapy

With scant data, RFK Jr. credits Trump for higher European drug prices

QuantX raises $85M Series B from Lilly, Sanofi Ventures

Despite FDA’s crackdown, pharma is still spending millions on ads

Lilly joins in vivo CAR-T sprint with $2.4B Orna acquisition

Galux raises $29M Series B; CSL teams up with Memo

#ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%